Project Number ADDF-17 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2020 View Full Project Details for Development and Commercialization of a Protein Misfolding Cyclic Amplification (PMCA) Clinical Test for Detection of Aggregates of Misfolded alpha-Synuclein in Plasma and Plasma Exosomes Research Categorization Primary Disease / Condition Multiple Dementias CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 1. Fluid Biomarkers a. CSF Biomarkers Researcher and Organization Principal Investigator Lebovitz, Russell Principal Investigator Lebovitz, Russell Awardee Organization Amprion Inc Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement ADDF-Neuroimaging and CSF Biomarkers Program FY Overall Cost $631,653 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States Program Official ADDF Grants Management
